Dr Scott Burgess, SCOTT BURGESS in Arnold, MD - Otolaryngology

Dr Scott Burgess, SCOTT BURGESS is a Otolaryngology physician based in Arnold, Maryland. Dr Scott Burgess is licensed to practice in Maryland (license number D0026658) and his current practice location is 710 White Swan Dr, Arnold, Maryland. He can be reached at his office (for appointments etc.) via phone at (410) 757-0753.

NPI number for Dr Scott Burgess is 1811270127 and his current mailing address is 710 White Swan Dr, Arnold, Maryland. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1811270127.

Contact Information

	Dr Scott Burgess, SCOTT BURGESS
	710 White Swan Dr, Arnold, MD 21012-1519
	(410) 757-0753
	Not Available

Physician's Profile

Full Name	Dr Scott Burgess
Gender	Male
Speciality	Otolaryngology
Location	710 White Swan Dr, Arnold, Maryland
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1811270127
Provider Enumeration Date: 09/22/2011
Last Update Date: 09/22/2011

Medical Identifiers

Medical identifiers for Dr Scott Burgess such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1811270127	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Y00000X	Otolaryngology	D0026658 (Maryland)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Scott Burgess is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Scott Burgess, SCOTT BURGESS 710 White Swan Dr, Arnold, MD 21012-1519 Ph: (410) 757-0753	Dr Scott Burgess, SCOTT BURGESS 710 White Swan Dr, Arnold, MD 21012-1519 Ph: (410) 757-0753

News Archive

BAT publishes new review of vaping products and their potential health effects

To mark World Vape Day, BAT has today published a comprehensive review of the scientific evidence for vaping products (e-cigarettes), their potential health effects and their role in Tobacco Harm Reduction.

PrediXcan method improves detection of genes linked to complex diseases, biological traits of interest

A new computational method developed by scientists from the University of Chicago improves the detection of genes that are likely to be causal for complex diseases and biological traits. The method, PrediXcan, estimates gene expression levels across the whole genome - a better measure of biological action than single mutations - and integrates it with genome-wide association study (GWAS) data.

Important player in the development of colon cancer

Cancer growth is a long, complex, multi-stage process involving a variety of different "players." This complexity is part of the difficulty facing cancer researchers. Meanwhile, each discovery or identification of a new "player," or previously unknown stage in the process, offers new opportunities for blocking the disease.

Nanoparticle (SpFN) vaccine candidate elicits multifactorial cellular immune responses against SARS-CoV-2 in vivo

Researchers have developed a promising new anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)vaccine candidate that utilizes nanotechnology and shows robust, long-lived immunity in mouse models.

Report assessing school-based policies that address the health of students released by AAFA

For over 8 million children with asthma, food allergies and related conditions, the school-house is a focal point for managing their diseases. Now for the second year in a row, the Asthma and Allergy Foundation of America (AAFA) has released a report assessing school-based policies that address student health for elementary, middle and high schools in all 50 states.

Dr Scott Burgess, SCOTT BURGESS - Otolaryngology in Arnold, MD